Skip to content

PanACEA

  • Contact us
  • Twitter
  • News
  • About Us
    • Mission
    • History
    • Governance
    • Donors
    • Scientific Network
  • Tuberculosis
    • Impact
    • Treatment
    • Drug development
  • Clinical Studies
    • Trial Design
    • PanACEA Studies
    • Vision for future Studies
  • Capacity Development

PanACEA in Lancet

Posted on April 1, 2014June 22, 2017 by admin

PanACEA investigators collaborate on comprehensive TB drug development review for Lancet Infectious Diseases special issue for World TB Day. http://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2813%2970328-1/fulltext#

Posted in news, Uncategorized

Post navigation

← PanACEA in the WHO Global Tuberculosis Report
Best Practices Awards Recognize Excellence in Clinical IT →

Recent Posts

  • PanACEA General Assembly
  • Press Release
  • PanACEA adds SUDOCU and PHENORIF trials to portfolio
  • Maximum tolerated dose of rifampicin identified
  • Dr. Francis Mhimbira
© PanACEA
  • edctp
  • European Union
  • Contact us
  • Twitter